MedPath

AZIDUS BRASIL PESQUISA CIENTIFICA E DESENVOLVIMENTO LTDA

🇧🇷Brazil
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

80

Active:2
Completed:29

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:17
Phase 2:18
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (77 trials with phase data)• Click on a phase to view related trials

Phase 3
38 (49.4%)
Phase 2
18 (23.4%)
Phase 1
17 (22.1%)
Early Phase 1
2 (2.6%)
Not Applicable
1 (1.3%)
Phase 4
1 (1.3%)

Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

Phase 3
Not yet recruiting
Conditions
Covid 19
Influenza
Interventions
Drug: Nitazoxanide 600Mg Oral Tablet / placebo oral tablet
First Posted Date
2025-02-10
Last Posted Date
2025-02-10
Lead Sponsor
Azidus Brasil
Target Recruit Count
340
Registration Number
NCT06817096

Safety of UFRJvac, Trivalent COVID-19 Vaccine

Not yet recruiting
Conditions
Healthy People
First Posted Date
2024-03-12
Last Posted Date
2024-03-12
Lead Sponsor
Azidus Brasil
Target Recruit Count
156
Registration Number
NCT06303635

Efficacy and Safety and Pharmacokinetics of Boya IVIG

Phase 3
Not yet recruiting
Conditions
Primary Immunodeficiency Disease
First Posted Date
2023-11-29
Last Posted Date
2023-11-29
Lead Sponsor
Azidus Brasil
Target Recruit Count
50
Registration Number
NCT06150833

Efficacy and Safety of NestaCell® in Huntington's Disease

Phase 3
Not yet recruiting
Conditions
Huntington Disease
First Posted Date
2023-10-24
Last Posted Date
2023-10-24
Lead Sponsor
Azidus Brasil
Target Recruit Count
120
Registration Number
NCT06097780

Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG

Phase 3
Not yet recruiting
Conditions
Primary Immunodeficiency Disease
First Posted Date
2023-10-18
Last Posted Date
2024-03-12
Lead Sponsor
Azidus Brasil
Target Recruit Count
50
Registration Number
NCT06089122
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.